Day One Biopharmaceuticals, Inc. (DAWN) - Quarterly Income Statement

Home
DAWN
Financials

7.51 (USD) • At close August 29, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	33.908	30.761	29.208	93.761	8.192	0	0.56	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	3.765	2.884	2.982	1.59	0.707	0.116	0.28	0.099	0.092	0.089	0.18	0.165	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	30.143	27.877	26.226	92.171	7.485	-0.116	0.28	-0.099	-0.092	-0.089	-0.18	-0.165	0	0	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0.889	0.906	0.898	0.983	0.914	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	36.149	39.619	61.823	33.563	92.106	40.21	37.348	33.163	32.182	27.828	26.02	22.035	22.56	15.003	43.584	9.849	9.914	12.632	4.165	2.537	1.437	0.961
General & Administrative Expenses Numbers are in millions	0	29.325	31.553	0	30.186	26.557	22.169	18.275	17.072	18.027	16.723	17.664	14.159	12.745	29.159	9.392	5.525	3.454	1.979	1.024	0.872	0.808
Selling & Marketing Expenses Numbers are in millions	0	0	-1.818	0	0	-0.116	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	28.968	29.325	29.735	28.972	30.186	26.441	22.169	18.275	17.072	18.027	16.723	17.664	14.159	12.745	29.159	9.392	5.525	3.454	1.979	1.024	0.872	0.808
Other Expenses Numbers are in millions	0	0	0	0	0	-0.01	-0.018	-0.003	-0.015	-0.004	-0.026	0.009	0	-0.001	0.014	0.007	-0.027	-0.008	-0.026	-0.001	0	-0.002
Operating Expenses Numbers are in millions	65.117	68.944	91.558	62.535	122.292	66.651	59.517	51.438	49.254	45.855	42.743	39.699	36.719	27.748	72.743	19.241	15.439	16.086	6.144	3.561	2.309	1.769
Operating Income Numbers are in millions	-34.974	-41.067	-65.332	29.636	-114.807	-66.767	-59.517	-51.438	-49.254	-45.855	-42.743	-39.699	-36.719	-27.748	-121.931	-19.241	-15.439	-16.086	-6.144	-3.561	-2.309	-1.769
Operating Income Ratio Numbers are in millions	-1.031	-1.335	-2.237	0.316	-14.015	0	-106.28	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	4.652	5.071	6.092	6.519	111.952	4.355	5.006	5.288	3.391	3.462	2.634	1.904	0.189	0.001	0.037	0.001	-0.034	-0.015	-29.456	-0.281	-0.1	-0.223
Income Before Tax Numbers are in millions	-30.322	-35.996	-59.24	36.155	-2.855	-62.412	-54.511	-46.15	-45.863	-42.393	-40.109	-37.795	-36.53	-27.747	-119.825	-19.24	-15.473	-16.101	-35.6	-3.842	-2.409	-1.992
Income Before Tax Ratio Numbers are in millions	-0.894	-1.17	-2.028	0.386	-0.349	0	-97.341	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	6.474	-0.882	1.552	0.073	0	-0.099	0	-7.017	-5.294	-3.799	-0.189	-0.003	0.004	0.007	-0.027	0	0	0	0	0
Net Income Numbers are in millions	-30.322	-35.996	-65.714	37.037	-4.407	-62.412	-54.511	-46.15	-45.863	-35.376	-34.815	-33.996	-36.53	-27.744	-119.829	-19.24	-14.282	-15.182	-34.377	-2.824	-1.76	-1.535
Net Income Ratio Numbers are in millions	-0.894	-1.17	-2.25	0.395	-0.538	0	-97.341	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.29	-0.35	-0.7	0.38	-0.051	-0.72	-0.62	-0.54	-0.61	-0.49	-0.47	-0.48	-0.6	-0.48	-1.93	-0.31	-0.23	-0.25	-0.56	-0.046	-0.028	-0.025
EPS Diluted Numbers are in millions	-0.29	-0.35	-0.7	0.38	-0.051	-0.72	-0.62	-0.54	-0.61	-0.49	-0.47	-0.48	-0.6	-0.48	-1.93	-0.31	-0.23	-0.25	-0.56	-0.046	-0.028	-0.025
EBITDA Numbers are in millions	-34.974	-40.173	-64.573	29.636	-114.494	-66.767	-59.504	-51.438	-49.254	-45.855	-42.728	-39.699	-36.586	-27.748	-21.97	-19.184	-15.39	-16.045	-35.543	-3.787	-2.353	-1.975
EBITDA Ratio Numbers are in millions	-1.031	-1.306	-2.211	0.316	-13.976	0	-106.257	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Day One Biopharmaceuticals, Inc.

NASDAQ:DAWN Add to watchlist

NASDAQ:DAWN